Ocrelizumab (Anti-CD20)
A2561
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameOcrelizumab (Anti-CD20)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionOcrelizumab (Anti-CD20) is a recombinant humanized monoclonal IgG1 antibody that selectively targets CD20 antigen present on B-cells. It is used to treat relapsing remitting multiple sclerosis. MW:145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203